This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 30 October-5 November 2022 and includes updates on chikungunya, dengue, COVID-19, increase in hepatitis cases in children, monkeypox, West Nile virus, Ebola virus disease due to Sudan ebolavirus, and seasonal influenza.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 2-8 October 2022 and includes updates on avian influenza, COVID-19, dengue, Ebola, invasive meningococcal disease, West Nile Virus, MERS-CoV, monkeypox, and hepatitis.
Clusters and outbreaks of hepatitis A virus (HAV) genotype IB with four unique but closely related HAV sequences have been reported in six European Union (EU) countries and in the United Kingdom (UK).
For 2020, 28 EU/EEA countries reported 4 824 confirmed cases of Shiga toxin -producing Escherichia coli (STEC) infection. The overall notification rate was 1.6 cases per 100 000 population. The highest notification rates were reported in Ireland, Malta, Denmark, and Norway. The EU/EEA notification rate decreased notably in 2020 compared with 2016-2019 due to the COVID-19 pandemic.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 28 August-3 September 2022 and includes updates on COVID-19, monkeypox, West Nile virus, increase in hepatitis cases of unknown aetiology in children, Vibrio, and poliomyelitis.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 7-13 August 2022 and includes updates on West Nile virus infection, COVID-19, monkeypox, measles, Crimean-Congo haemorrhagic fever, Langya henipavirus, dengue, mass gatherings at the Birmingham 2022 commonwealth games, Vibrio growth, swine influenza and polio.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 24 -30 July and includes updates on COVID-19, monkeypox, West Nile virus, increase in hepatitis of unknown aetiology in children, mass gatherings in the Birmingham 2022 Commonwealth games, Vibrio growth, Marburg disease, Chikungunya, dengue, and wild poliovirus.
For 2020, 29 EU/EEA Member States reported 14 428 cases of hepatitis B virus (HBV) infection. Excluding the five countries that only reported acute cases, the number of cases (14 137) corresponds to a crude rate of 4.2 cases per 100 000 population.